Exagen, Inc. (XGN)
7.48
+0.21
(+2.89%)
USD |
NASDAQ |
Oct 26, 16:00
7.48
0.00 (0.00%)
After-Hours: 18:57
Exagen Net Income (TTM) : -18.92M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -18.92M |
| March 31, 2026 | -20.17M |
| December 31, 2025 | -19.95M |
| September 30, 2025 | -19.04M |
| June 30, 2025 | -16.98M |
| March 31, 2025 | -15.51M |
| December 31, 2024 | -15.12M |
| September 30, 2024 | -16.93M |
| June 30, 2024 | -17.31M |
| March 31, 2024 | -19.36M |
| December 31, 2023 | -23.69M |
| September 30, 2023 | -32.47M |
| June 30, 2023 | -35.15M |
| March 31, 2023 | -44.80M |
| December 31, 2022 | -47.39M |
| September 30, 2022 | -40.09M |
| June 30, 2022 | -39.17M |
| March 31, 2022 | -30.91M |
| December 31, 2021 | -26.85M |
| September 30, 2021 | -23.25M |
| June 30, 2021 | -20.38M |
| March 31, 2021 | -17.33M |
| Date | Value |
|---|---|
| December 31, 2020 | -16.69M |
| September 30, 2020 | -16.64M |
| June 30, 2020 | -29.08M |
| March 31, 2020 | -28.50M |
| December 31, 2019 | -25.64M |
| September 30, 2019 | -23.55M |
| June 30, 2019 | -8.562M |
| March 31, 2019 | -7.923M |
| December 31, 2018 | -9.164M |
| September 30, 2018 | -10.38M |
| June 30, 2018 | -12.13M |
| March 31, 2018 | -19.67M |
| December 31, 2015 | -19.18M |
| September 30, 2015 | -17.95M |
| June 30, 2015 | -19.26M |
| March 31, 2015 | -13.57M |
| December 31, 2014 | -13.68M |
| September 30, 2014 | -18.83M |
| June 30, 2014 | -16.45M |
| March 31, 2014 | -14.78M |
| December 31, 2013 | -13.50M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Myriad Genetics, Inc. | -112.60M |
| BioRestorative Therapies, Inc. | -11.06M |
| CareDx, Inc. | 111.01M |
| Natera, Inc. | -192.35M |
| Sera Prognostics, Inc. | -33.23M |